# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-293688
Filing Date
2021-10-07
Accepted
2021-10-07 07:12:48
Documents
128
Period of Report
2021-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 20-F | d185056d20f.htm iXBRL | 20-F | 2780768
2 | EX-4.18 | d185056dex418.htm | EX-4.18 | 390077
3 | EX-4.19 | d185056dex419.htm | EX-4.19 | 278641
4 | EX-4.20 | d185056dex420.htm | EX-4.20 | 232430
5 | EX-12.1 | d185056dex121.htm | EX-12.1 | 10404
6 | EX-12.2 | d185056dex122.htm | EX-12.2 | 10723
7 | EX-13.1 | d185056dex131.htm | EX-13.1 | 6122
8 | EX-15.1 | d185056dex151.htm | EX-15.1 | 2113
14 | GRAPHIC | g185056g185056g48n95.jpg | GRAPHIC | 220816
| Complete submission text file | 0001193125-21-293688.txt |  | 12815491

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA | kzia-20210630.xsd | EX-101.SCH | 95757
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | kzia-20210630_cal.xml | EX-101.CAL | 45917
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | kzia-20210630_def.xml | EX-101.DEF | 309249
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | kzia-20210630_lab.xml | EX-101.LAB | 533139
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | kzia-20210630_pre.xml | EX-101.PRE | 464066
15 | EXTRACTED XBRL INSTANCE DOCUMENT | d185056d20f_htm.xml | XML | 2368627

Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-29962 | Film No.: 211311046
SIC: 2834 Pharmaceutical Preparations